Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Humanization Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Monoclonal Antibodies
1.2.3 Bispecific Antibodies
1.2.4 CDR Grafted Antibodies
1.3 Market by Application
1.3.1 Global Antibody Humanization Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 HIV
1.3.3 SARS
1.3.4 RSV
1.3.5 Prion
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Humanization Market Perspective (2018-2034)
2.2 Antibody Humanization Growth Trends by Region
2.2.1 Global Antibody Humanization Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Antibody Humanization Historic Market Size by Region (2018-2024)
2.2.3 Antibody Humanization Forecasted Market Size by Region (2024-2034)
2.3 Antibody Humanization Market Dynamics
2.3.1 Antibody Humanization Industry Trends
2.3.2 Antibody Humanization Market Drivers
2.3.3 Antibody Humanization Market Challenges
2.3.4 Antibody Humanization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Humanization Players by Revenue
3.1.1 Global Top Antibody Humanization Players by Revenue (2018-2024)
3.1.2 Global Antibody Humanization Revenue Market Share by Players (2018-2024)
3.2 Global Antibody Humanization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Humanization Revenue
3.4 Global Antibody Humanization Market Concentration Ratio
3.4.1 Global Antibody Humanization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Humanization Revenue in 2022
3.5 Antibody Humanization Key Players Head office and Area Served
3.6 Key Players Antibody Humanization Product Solution and Service
3.7 Date of Enter into Antibody Humanization Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Humanization Breakdown Data by Type
4.1 Global Antibody Humanization Historic Market Size by Type (2018-2024)
4.2 Global Antibody Humanization Forecasted Market Size by Type (2024-2034)
5 Antibody Humanization Breakdown Data by Application
5.1 Global Antibody Humanization Historic Market Size by Application (2018-2024)
5.2 Global Antibody Humanization Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Antibody Humanization Market Size (2018-2034)
6.2 North America Antibody Humanization Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Antibody Humanization Market Size by Country (2018-2024)
6.4 North America Antibody Humanization Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Humanization Market Size (2018-2034)
7.2 Europe Antibody Humanization Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Antibody Humanization Market Size by Country (2018-2024)
7.4 Europe Antibody Humanization Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Humanization Market Size (2018-2034)
8.2 Asia-Pacific Antibody Humanization Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Antibody Humanization Market Size by Region (2018-2024)
8.4 Asia-Pacific Antibody Humanization Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Humanization Market Size (2018-2034)
9.2 Latin America Antibody Humanization Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Antibody Humanization Market Size by Country (2018-2024)
9.4 Latin America Antibody Humanization Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Humanization Market Size (2018-2034)
10.2 Middle East & Africa Antibody Humanization Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Antibody Humanization Market Size by Country (2018-2024)
10.4 Middle East & Africa Antibody Humanization Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Accurus Biosciences
11.1.1 Accurus Biosciences Company Detail
11.1.2 Accurus Biosciences Business Overview
11.1.3 Accurus Biosciences Antibody Humanization Introduction
11.1.4 Accurus Biosciences Revenue in Antibody Humanization Business (2018-2024)
11.1.5 Accurus Biosciences Recent Development
11.2 IONTAS
11.2.1 IONTAS Company Detail
11.2.2 IONTAS Business Overview
11.2.3 IONTAS Antibody Humanization Introduction
11.2.4 IONTAS Revenue in Antibody Humanization Business (2018-2024)
11.2.5 IONTAS Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Antibody Humanization Introduction
11.3.4 Lonza Revenue in Antibody Humanization Business (2018-2024)
11.3.5 Lonza Recent Development
11.4 Oak BioSciences
11.4.1 Oak BioSciences Company Detail
11.4.2 Oak BioSciences Business Overview
11.4.3 Oak BioSciences Antibody Humanization Introduction
11.4.4 Oak BioSciences Revenue in Antibody Humanization Business (2018-2024)
11.4.5 Oak BioSciences Recent Development
11.5 Panorama Research
11.5.1 Panorama Research Company Detail
11.5.2 Panorama Research Business Overview
11.5.3 Panorama Research Antibody Humanization Introduction
11.5.4 Panorama Research Revenue in Antibody Humanization Business (2018-2024)
11.5.5 Panorama Research Recent Development
11.6 PX'Therapeutics
11.6.1 PX'Therapeutics Company Detail
11.6.2 PX'Therapeutics Business Overview
11.6.3 PX'Therapeutics Antibody Humanization Introduction
11.6.4 PX'Therapeutics Revenue in Antibody Humanization Business (2018-2024)
11.6.5 PX'Therapeutics Recent Development
11.7 Yurogen Biosystems
11.7.1 Yurogen Biosystems Company Detail
11.7.2 Yurogen Biosystems Business Overview
11.7.3 Yurogen Biosystems Antibody Humanization Introduction
11.7.4 Yurogen Biosystems Revenue in Antibody Humanization Business (2018-2024)
11.7.5 Yurogen Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antibody Humanization Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Bispecific Antibodies
Table 4. Key Players of CDR Grafted Antibodies
Table 5. Global Antibody Humanization Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global Antibody Humanization Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Antibody Humanization Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Antibody Humanization Market Share by Region (2018-2024)
Table 9. Global Antibody Humanization Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Antibody Humanization Market Share by Region (2024-2034)
Table 11. Antibody Humanization Market Trends
Table 12. Antibody Humanization Market Drivers
Table 13. Antibody Humanization Market Challenges
Table 14. Antibody Humanization Market Restraints
Table 15. Global Antibody Humanization Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Antibody Humanization Market Share by Players (2018-2024)
Table 17. Global Top Antibody Humanization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Humanization as of 2022)
Table 18. Ranking of Global Top Antibody Humanization Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Antibody Humanization Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antibody Humanization Product Solution and Service
Table 22. Date of Enter into Antibody Humanization Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Humanization Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Antibody Humanization Revenue Market Share by Type (2018-2024)
Table 26. Global Antibody Humanization Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Antibody Humanization Revenue Market Share by Type (2024-2034)
Table 28. Global Antibody Humanization Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Antibody Humanization Revenue Market Share by Application (2018-2024)
Table 30. Global Antibody Humanization Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Antibody Humanization Revenue Market Share by Application (2024-2034)
Table 32. North America Antibody Humanization Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 33. North America Antibody Humanization Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Antibody Humanization Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Antibody Humanization Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 36. Europe Antibody Humanization Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Antibody Humanization Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Antibody Humanization Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Asia-Pacific Antibody Humanization Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Antibody Humanization Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Antibody Humanization Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 42. Latin America Antibody Humanization Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Antibody Humanization Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Antibody Humanization Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Middle East & Africa Antibody Humanization Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Antibody Humanization Market Size by Country (2024-2034) & (US$ Million)
Table 47. Accurus Biosciences Company Detail
Table 48. Accurus Biosciences Business Overview
Table 49. Accurus Biosciences Antibody Humanization Product
Table 50. Accurus Biosciences Revenue in Antibody Humanization Business (2018-2024) & (US$ Million)
Table 51. Accurus Biosciences Recent Development
Table 52. IONTAS Company Detail
Table 53. IONTAS Business Overview
Table 54. IONTAS Antibody Humanization Product
Table 55. IONTAS Revenue in Antibody Humanization Business (2018-2024) & (US$ Million)
Table 56. IONTAS Recent Development
Table 57. Lonza Company Detail
Table 58. Lonza Business Overview
Table 59. Lonza Antibody Humanization Product
Table 60. Lonza Revenue in Antibody Humanization Business (2018-2024) & (US$ Million)
Table 61. Lonza Recent Development
Table 62. Oak BioSciences Company Detail
Table 63. Oak BioSciences Business Overview
Table 64. Oak BioSciences Antibody Humanization Product
Table 65. Oak BioSciences Revenue in Antibody Humanization Business (2018-2024) & (US$ Million)
Table 66. Oak BioSciences Recent Development
Table 67. Panorama Research Company Detail
Table 68. Panorama Research Business Overview
Table 69. Panorama Research Antibody Humanization Product
Table 70. Panorama Research Revenue in Antibody Humanization Business (2018-2024) & (US$ Million)
Table 71. Panorama Research Recent Development
Table 72. PX'Therapeutics Company Detail
Table 73. PX'Therapeutics Business Overview
Table 74. PX'Therapeutics Antibody Humanization Product
Table 75. PX'Therapeutics Revenue in Antibody Humanization Business (2018-2024) & (US$ Million)
Table 76. PX'Therapeutics Recent Development
Table 77. Yurogen Biosystems Company Detail
Table 78. Yurogen Biosystems Business Overview
Table 79. Yurogen Biosystems Antibody Humanization Product
Table 80. Yurogen Biosystems Revenue in Antibody Humanization Business (2018-2024) & (US$ Million)
Table 81. Yurogen Biosystems Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Humanization Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Antibody Humanization Market Share by Type: 2022 VS 2034
Figure 3. Monoclonal Antibodies Features
Figure 4. Bispecific Antibodies Features
Figure 5. CDR Grafted Antibodies Features
Figure 6. Global Antibody Humanization Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Antibody Humanization Market Share by Application: 2022 VS 2034
Figure 8. HIV Case Studies
Figure 9. SARS Case Studies
Figure 10. RSV Case Studies
Figure 11. Prion Case Studies
Figure 12. Antibody Humanization Report Years Considered
Figure 13. Global Antibody Humanization Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Antibody Humanization Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Antibody Humanization Market Share by Region: 2022 VS 2034
Figure 16. Global Antibody Humanization Market Share by Players in 2022
Figure 17. Global Top Antibody Humanization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Humanization as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Antibody Humanization Revenue in 2022
Figure 19. North America Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Antibody Humanization Market Share by Country (2018-2034)
Figure 21. United States Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Antibody Humanization Market Share by Country (2018-2034)
Figure 25. Germany Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Antibody Humanization Market Share by Region (2018-2034)
Figure 33. China Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Antibody Humanization Market Share by Country (2018-2034)
Figure 41. Mexico Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Antibody Humanization Market Share by Country (2018-2034)
Figure 45. Turkey Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Antibody Humanization Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Accurus Biosciences Revenue Growth Rate in Antibody Humanization Business (2018-2024)
Figure 48. IONTAS Revenue Growth Rate in Antibody Humanization Business (2018-2024)
Figure 49. Lonza Revenue Growth Rate in Antibody Humanization Business (2018-2024)
Figure 50. Oak BioSciences Revenue Growth Rate in Antibody Humanization Business (2018-2024)
Figure 51. Panorama Research Revenue Growth Rate in Antibody Humanization Business (2018-2024)
Figure 52. PX'Therapeutics Revenue Growth Rate in Antibody Humanization Business (2018-2024)
Figure 53. Yurogen Biosystems Revenue Growth Rate in Antibody Humanization Business (2018-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed